The FAT1‐HR subgroup showed significantly lower five‐year OS rates than the FAT1‐LR subgroup, among HNSCC patients who received radiotherapy (p = 3e−04; Fig. 3A). The gene discussed is FAT1; the disease is head and neck squamous cell carcinoma.